Received Jun 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | UNK | — |
Late 2nd dose; This non-serious case was reported by a other health professional via sales rep and described the occurrence of incomplete course of vaccination in a adolescent patient who received Men B NVS (Bexsero) for prophylaxis. Previously administered products included Bexsero (1st dose received on an unknown date). On an unknown date, the patient did not receive the 2nd dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced incomplete course of vaccination (Verbatim: Late 2nd dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 11-JUN-2025 Field Representative asked for information on what to tell an adolescent if it had been longer than 6 months since their first dose of Bexsero which led to incomplete course of vaccination Do they go ahead and give the second dose, or do they re-start the series?